Health Care & Life Sciences » Pharmaceuticals | Beijing Beilu Pharmaceutical Co. Ltd.

Beijing Beilu Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Beijing Beilu Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
2,225,444
0.57%
-853,439
1.2%
12/31/2017
Fund Kexun
1,343,118
0.35%
0
0.4%
12/31/2017
618,885
0.16%
618,885
0.25%
12/31/2017
595,463
0.16%
-49,300
1.67%
12/31/2017
271,000
0.07%
271,000
0.25%
12/31/2017
138,450
0.04%
18,500
0.19%
12/31/2017
First-Trust Advantage Growth Flexible Balanced Fund
30,000
0.01%
0
0.66%
12/31/2017
5,500
0%
-200
0.1%
12/31/2017
3,600
0%
-700
0.09%
12/31/2017
0
0%
-57,900
0%
12/31/2017

About Beijing Beilu Pharmaceutical Co.

View Profile
Address
7/F, Blk A, Fenglan Intl Office Bldg
Beijing Beijing 100082
China
Employees -
Website http://www.beilu.com.cn
Updated 07/08/2019
Beijing Beilu Pharmaceutical Co., Ltd. engages in the development, production, and sale of pharmaceutical product. Its products cover contrast medium product, glimepiride, and anti-anxiety product. The contrast medium product includes ferric ammonium citrate, gadopentetate, and iohexol injection.